Healthcare provider profile · identity verified

David H Curl, PA

Physician Assistant · CHAPEL HILL, NC · NPI 1467529644

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	653	88
Atorvastatin Calcium	Atorvastatin Calcium	587	101
Famotidine	Famotidine	379	53
Lisinopril	Lisinopril	376	60
Gabapentin	Gabapentin	324	37
Trazodone Hcl	Trazodone Hcl	294	62
Levothyroxine Sodium	Levothyroxine Sodium	254	40
Metformin Hcl	Metformin Hcl	251	39
Tamsulosin Hcl	Tamsulosin Hcl	233	33
Sertraline Hcl	Sertraline Hcl	231	44
Furosemide	Furosemide	229	37
Mirtazapine	Mirtazapine	184	35
Metoprolol Succinate	Metoprolol Succinate	179	31
Losartan Potassium	Losartan Potassium	162	25
Carvedilol	Carvedilol	153	24
Eliquis	Apixaban	142	18
Donepezil Hcl	Donepezil Hcl	135	26
Escitalopram Oxalate	Escitalopram Oxalate	133	20
Memantine Hcl	Memantine Hcl	131	17
Potassium Chloride	Potassium Chloride	128	24
Risperidone	Risperidone	121	25
Metoprolol Tartrate	Metoprolol Tartrate	119	21
Oxycodone Hcl	Oxycodone Hcl	119	25
Tramadol Hcl	Tramadol Hcl	113	27
Quetiapine Fumarate	Quetiapine Fumarate	108	19
Pravastatin Sodium	Pravastatin Sodium	105	15
Simvastatin	Simvastatin	102	17
Omeprazole	Omeprazole	101	26
Clopidogrel	Clopidogrel Bisulfate	92	13
Divalproex Sodium	Divalproex Sodium	91	17
Olanzapine	Olanzapine	89	14
Pantoprazole Sodium	Pantoprazole Sodium	89	18
Lorazepam	Lorazepam	86	26
Fluticasone Propionate	Fluticasone Propionate	85	24
Montelukast Sodium	Montelukast Sodium	85	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	84	11
Lamotrigine	Lamotrigine	80	12
Levetiracetam	Levetiracetam	80	12
Rosuvastatin Calcium	Rosuvastatin Calcium	75	13
Buspirone Hcl	Buspirone Hcl	71	14
Spironolactone	Spironolactone	70	suppressed
Allopurinol	Allopurinol	67	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	suppressed
Meloxicam	Meloxicam	66	16
Latanoprost	Latanoprost	64	16
Hydralazine Hcl	Hydralazine Hcl	62	suppressed
Metformin Hcl Er	Metformin Hcl	61	suppressed
Aripiprazole	Aripiprazole	50	suppressed
Finasteride	Finasteride	50	suppressed
Pregabalin	Pregabalin	49	12
Clonazepam	Clonazepam	47	suppressed
Myrbetriq	Mirabegron	47	suppressed
Timolol Maleate	Timolol Maleate	46	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	suppressed
Jardiance	Empagliflozin	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	42	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	20
Xarelto	Rivaroxaban	37	suppressed
Valsartan	Valsartan	35	suppressed
Amantadine	Amantadine Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Torsemide	Torsemide	33	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Nystatin	Nystatin	32	17
Solifenacin Succinate	Solifenacin Succinate	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Prednisone	Prednisone	28	suppressed
Atenolol	Atenolol	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Baclofen	Baclofen	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	19
Januvia	Sitagliptin Phosphate	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Lactulose	Lactulose	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Methimazole	Methimazole	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Creon	Lipase/Protease/Amylase	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Rivastigmine	Rivastigmine Tartrate	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Zonisamide	Zonisamide	19	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Clozapine	Clozapine	18	suppressed
Glycopyrrolate	Glycopyrrolate	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Azithromycin	Azithromycin	16	15
Diclofenac Sodium	Diclofenac Sodium	16	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Rhopressa	Netarsudil Mesylate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Carbamazepine	Carbamazepine	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Combigan	Brimonidine Tartrate/Timolol	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Serevent Diskus	Salmeterol Xinafoate	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Dilantin	Phenytoin Sodium Extended	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Travoprost	Travoprost	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error